Grant to Fund CAR T-cell Trial for HER2-Positive BC with Brain Metastases
News
The California Institute for Regenerative Medicine (CIRM) has granted a $9.28 million award to a group of City of Hope researchers carrying out a first-in-human Phase 1 clinical trial testing ... Read more